Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204197
Max Phase: Preclinical
Molecular Formula: C28H28F3N5O
Molecular Weight: 507.56
Associated Items:
ID: ALA5204197
Max Phase: Preclinical
Molecular Formula: C28H28F3N5O
Molecular Weight: 507.56
Associated Items:
Canonical SMILES: Cc1ccc(Cc2c(C)nc3c(C(=O)N4CCN(c5ccc(C(F)(F)F)cc5)CC4)cnn3c2C)cc1
Standard InChI: InChI=1S/C28H28F3N5O/c1-18-4-6-21(7-5-18)16-24-19(2)33-26-25(17-32-36(26)20(24)3)27(37)35-14-12-34(13-15-35)23-10-8-22(9-11-23)28(29,30)31/h4-11,17H,12-16H2,1-3H3
Standard InChI Key: QXMLOAUNAUUWLN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 507.56 | Molecular Weight (Monoisotopic): 507.2246 | AlogP: 5.23 | #Rotatable Bonds: 4 |
Polar Surface Area: 53.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 2.86 | CX LogP: 5.50 | CX LogD: 5.50 |
Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.38 | Np Likeness Score: -1.85 |
1. Zhang G, Wang F, Li S, Cheng KW, Zhu Y, Huo R, Abdukirim E, Kang G, Chou TF.. (2022) Discovery of small-molecule inhibitors of RUVBL1/2 ATPase., 62 [PMID:35364523] [10.1016/j.bmc.2022.116726] |
Source(1):